Alvotech Reports Results for the First Six Months of 2025 and Provides a Business UpdateGlobeNewsWire • 08/13/25
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business UpdateGlobeNewsWire • 08/13/25
Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a BetZacks Investment Research • 08/13/25
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDTGlobeNewsWire • 08/06/25
Wall Street Analysts See a 91.05% Upside in Alvotech (ALVO): Can the Stock Really Move This High?Zacks Investment Research • 07/24/25
Down 6.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Alvotech (ALVO)Zacks Investment Research • 07/17/25
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in SwitzerlandGlobeNewsWire • 07/09/25
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in SwitzerlandGlobeNewsWire • 07/09/25
Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuersGlobeNewsWire • 07/03/25
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)GlobeNewsWire • 07/01/25
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)GlobeNewsWire • 06/25/25
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)GlobeNewsWire • 06/25/25
European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea® (aflibercept)GlobeNewsWire • 06/23/25
European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea® (aflibercept)GlobeNewsWire • 06/23/25
Alvotech's Private Placement Completed with Delivery of SDRs and Shares to InvestorsGlobeNewsWire • 06/11/25
Alvotech's Private Placement Completed with Delivery of SDRs and Shares to InvestorsGlobeNewsWire • 06/11/25
Wall Street Analysts Think Alvotech (ALVO) Could Surge 72.61%: Read This Before Placing a BetZacks Investment Research • 06/09/25
Alvotech Participates in the Goldman Sachs Global Healthcare Conference in MiamiGlobeNewsWire • 06/06/25
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in MiamiGlobeNewsWire • 06/06/25